AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Indivior PLC

Board/Management Information Mar 8, 2019

4923_rns_2019-03-08_97dd7ac3-59a8-435f-95b8-558d8cc6c9ab.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3211S

Indivior PLC

08 March 2019

Indivior PLC - Directorate Change

Indivior PLC announces that Dr. Yvonne Greenstreet, Non-Executive Director, has confirmed that she will retire from the Board with effect from March 31, 2019.  As announced in November 2018, Dr. Greenstreet had already advised that she would not seek re-appointment at the Company's 2019 AGM.

The Board has reviewed its composition and that of its Committees and confirms that it has no current plans to recruit a successor to Dr. Greenstreet.  Tom McLellan will be appointed Chair of the Science & Policy Committee with effect from March 31, 2019.  Dr. McLellan has served as a Member of the Science & Policy Committee since his appointment as a Non-Executive Director in November 2014.

Howard Pien, Chair of Indivior, commented:

'Yvonne has served as a Non-Executive Director since the Company's listing on the London Stock Exchange in 2014 and has been Chair of the Science & Policy Committee and a member of the Audit Committee throughout her tenure.  I would like to thank Yvonne for her exemplary contribution to the Company.  The Board and I wish her well for the future.

We are pleased to appoint Tom McLellan as Chair of the Science & Policy Committee.  Tom's extensive experience in the field of addiction spans more than 35 years as a career researcher in the treatment and policy-making around substance use and abuse and makes him a natural successor as Committee Chair.'

Note:

This announcement is made pursuant to Listing Rule 9.6.11(2).

No remuneration is payable consequent upon or in respect of Yvonne Greenstreet's retirement. She will receive pro-rated Board fees and Audit Committee and Science & Policy Committee fees, as applicable, to the date of her retirement. She will not receive any payment for loss of office or any other payments in relation to her retirement.

Contact

Kathryn Hudson, Company Secretary

Tel: +44 (0)1753 423940

Indivior PLC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOAJPMMTMBJMBLL

Talk to a Data Expert

Have a question? We'll get back to you promptly.